EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Author： Dubsky P.   Filipits M.   Jakesz R.   Rudas M.   Singer C. F.   Greil R.   Dietze O.   Luisser I.   Klug E.   Sedivy R.   Bachner M.   Mayr D.   Schmidt M.   Gehrmann M. C.   Petry C.   Weber K. E.   Kronenwett R.   Brase J. C.   Gnant M.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.3, 2013-03, pp. : 640-647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer

By          

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 66-71

Spandidos Publications

Access to resources Recommend Favorite

FOXA1 is an independent prognostic marker for ER-positive breast cancer

By Mehta Rutika  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 881-890

Springer Publishing Company

Access to resources Recommend Favorite

Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer

By Hoesel Anneke  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 859-869

Springer Publishing Company

Access to resources Recommend Favorite

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

By Eiermann W.   Rezai M.   Kmmel S.   Khn T.   Warm M.   Friedrichs K.   Schneeweiss A.   Markmann S.   Eggemann H.   Hilfrich J.   Jackisch C.   Witzel I.   Eidtmann H.   Bachinger A.   Hell S.   Blohmer J.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 618-624

Oxford University Press

Access to resources Recommend Favorite

Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients

By Naoi Yasuto  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 633-641

Springer Publishing Company

Access to resources Recommend Favorite